Grifols News, Grifols Quote, GRFS Quote

Grifols (NQ:GRFS) Delayed: 7.55 -0.1 (1.31%)

Prev. Close

$7.65

Today 6M 1Y 5Y

Open

$7.67

52 Wk High

$35.35

52 Wk Low

$14.07

Day High

$7.72

Day Low

$7.55

P/E

N/A

EPS

$0.00

Volume

513,348

Friends, Peers and Foes (?): GRF, 0RDU, GRF-P GIKLY (more...)

ALERTS | RSS

Sep 4, 2026 06:07 AM BofA Securities Reiterates Buy Rating on Grifols SA (GRF:SM) (GRFS)
Aug 10, 2026 07:01 AM Grifols completes patient follow-up in phase 3 alpha-1 lung study
Aug 10, 2026 07:00 AM Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency
Jul 30, 2026 10:49 AM Form 6-K Grifols SA For: Jul 30
Jul 29, 2026 06:02 AM Form 6-K Grifols SA For: Jul 28
Jul 16, 2026 08:01 AM Grifols starts two Phase 3 trials to expand immunoglobulin labels
Jul 16, 2026 08:00 AM Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
Jun 22, 2026 02:18 PM Form 6-K Grifols SA For: Jun 22
Jun 18, 2026 04:00 PM Form 6-K Grifols SA For: Jun 18
Jun 15, 2026 08:02 AM Grifols launches FESILTY fibrinogen concentrate in the US

Entities mentioned with GRFS

View All Entities